PubMed · 10362283
Does maximizing programmed cell death necessarily yield an optimum clinical advantage?
Abstract
Generally it has been believed that a maximum therapeutic induction of programmed cell death in cancer cells is universally desirable. As a corollary, the presence of Bcl-2, a major anti-programmed cell death protein, is considered an unfavorable prognostic sign. The latter is not and the former may not be universally true.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
D Ou, K M Anderson, W Leslie, P Bonomi, J E Harris. 1999. Does maximizing programmed cell death necessarily yield an optimum clinical advantage?. https://doi.org/10.1054/mehy.1998.0839
Cite the original work for its findings. Save a collection to share your selection of sources.